Publications by authors named "Haiyan Bian"

8Publications

Tuning isoform selectivity and bortezomib sensitivity with a new class of alkenyl indene PDI inhibitor.

Eur J Med Chem 2020 Jan 21;186:111906. Epub 2019 Nov 21.

Department of Cell and Molecular Pharmacology & Experimental Therapeutics, College of Medicine, Medical University of South Carolina, Charleston, SC, USA. Electronic address:

View Article and Find Full Text PDF
January 2020

Inhibitors of the protein disulfide isomerase family for the treatment of multiple myeloma.

Leukemia 2019 04 12;33(4):1011-1022. Epub 2018 Oct 12.

Department of Cell and Molecular Pharmacology & Experimental Therapeutics, College of Medicine, Medical University of South Carolina, Charleston, SC, USA.

View Article and Find Full Text PDF
April 2019

Dipeptide Prodrugs of the Glutamate Modulator Riluzole.

ACS Med Chem Lett 2018 Jul 15;9(7):752-756. Epub 2018 Jun 15.

Fox Chase Chemical Diversity Center, Inc., 3805 Old Easton Road, Doylestown, Pennsylvania 18902, United States.

View Article and Find Full Text PDF
July 2018

High-Throughput Screening Uncovers Novel Botulinum Neurotoxin Inhibitor Chemotypes.

ACS Comb Sci 2016 08 20;18(8):461-74. Epub 2016 Jul 20.

Department of Chemistry, The Scripps Research Institute , 10550 North Torrey Pines Road, La Jolla, California 92037, United States.

View Article and Find Full Text PDF
August 2016

Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors.

Bioorg Med Chem Lett 2014 Feb 9;24(4):1116-21. Epub 2014 Jan 9.

Fox Chase Chemical Diversity Center, Inc., 3805 Old Easton Road, Doylestown, PA 18902, United States.

View Article and Find Full Text PDF
February 2014

Indole-glucosides as novel sodium glucose co-transporter 2 (SGLT2) inhibitors. Part 2.

Bioorg Med Chem Lett 2006 Mar 27;16(6):1696-701. Epub 2005 Dec 27.

Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Rt. 202, PO Box 300, Raritan, NJ 08869, USA.

View Article and Find Full Text PDF
March 2006

Heteroaryl-O-glucosides as novel sodium glucose co-transporter 2 inhibitors. Part 1.

Bioorg Med Chem Lett 2005 Dec 28;15(23):5202-6. Epub 2005 Sep 28.

Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Rt. 202, PO Box 300, Raritan, NJ 08869, USA.

View Article and Find Full Text PDF
December 2005